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Background. Recent reports have found a positive relationship between periodontitis and the hormones cortisol and
dehydroepiandrosterone (DHEA). We investigated the associations between those levels and periodontitis in never-smokers and
smokers of elderly subjects. Subjects and Methods. Cortisol and DHEA levels in saliva were determined in 171 subjects (85 males,
86 females), with clinical examinations including probing depth (PD) and clinical attachment loss (CAL) also performed. Results.
Smoking had eﬀects on cortisol and DHEA levels, and those were signiﬁcantly associated with severe PD and CAL in never-
smokers. According to ROC analysis, the cutoﬀ values of cortisol and DHEA to obtain the optimal sensitivity and speciﬁcity
for detecting severe periodontitis were 2.06ng/mL and 60.24pg/mL, respectively, for PD, and 2.12ng/mL and 61.78pg/mL,
respectively, for CAL. Conclusions. Assessment of hormone levels may be a useful screening method for periodontitis, though
l i m i t e dt on e v e r - s m o k e r s .
Copyright © 2009 Toshihiro Ansai et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
A number of investigators have proposed an association
between periodontitis and psychosocial stress and the
majority of studies in a systematic review [1]f o u n d
a positive relationship between stress/psychological fac-
tors and periodontal disease. However, the relationship
between periodontitis and stress-related hormones in saliva
is poorly understood. In general, the stress system consists
of brain elements, of which the main components are the
corticotropin-releasing hormone (CRH) and locus ceruleus-
norepinephrine/autonomic systems, as well as their periph-
eral eﬀectors, the hypothalamic-pituitary-adrenal (HPA)
axis, and sympatho-adrenomedullary system [2]. A well-
known stress-related hormone is cortisol, while its salivary
level reliably reﬂects HPA activity and has long been used in
human psychological studies as a biological marker of stress
[3]. Further, DHEA is also known as an HPA-related steroid
hormone and has a positive correlation with depression
severity [4, 5]. However, few reports regarding salivary
DHEA have been presented in the dental ﬁeld.
Smoking is associated with elevated cortisol and DHEA
levels, as it increases the levels of adrenocorticotropin
hormone (ACTH) [6]. In addition, smoking is also a major
risk for periodontitis [7] and considered likely to be a
signiﬁcant mediator in the relationship between stress-
related disorders and the HPA axis [8]. However, to date
scant attention has been given to smoking regarding the
association between those hormones and periodontal status.
We hypothesized that measurement of these hormone levels
would be useful for screening for periodontitis in patients
who never smoked, since smoking is a stronger risk factor
for periodontitis. In the present study, we investigated the
associations between those levels and periodontitis in never-
smokersandsmokers.WealsoassessedcortisolandDHEAas
practical candidate biomarkers for screening of periodontal
disease by using receiver operating characteristic (ROC)
analyses.2 International Journal of Dentistry
2.SubjectsandMethods
2.1. Population and Samples. The subjects in this cross-
sectional study were recruited from members of two senior
citizen colleges in Kitakyushu City, Japan. The study sam-
ple consisted of community-dwelling, independently living
elderly people aged 60 years old and older who attended
lecturesoncea week. Thesecollegesarepartofthe adultedu-
cational system supported by the government of Kitakyushu
City, which enrolls students as volunteers for a period of
one year. The course of study focused not only on health
topics but also on other topics of interest to elderly people,
suchasﬁnanceandculture.Thestudypopulationvoluntarily
participated in oral and systemic examinations and initially
consisted of 231 subjects (116 males, 115 females) residing
in Fukuoka Prefecture, Japan. All of the subjects were
independent in daily activities, with none hospitalized at
the time of the study, as described previously [9]. Exclusion
criteria were as follows: (1) individuals who chronically used
corticosteroids and/or immune suppressor drugs as well as
those with immune suppressor diseases; (2) individuals with
missing questionnaires or saliva data; (3) individuals who
used antibiotics within the last 6 months, had symptoms
of acute illness, or had any apparent oral infections; and
(4) individuals with fewer than 3 natural teeth. As a result,
we evaluated a total of 171 subjects (85 males, 86 females;
mean age 68.4 ± 4.46 years old) in the present study. We
also assessed the diﬀerences between the 171 subjects who
completed the study and the 60 subjects had been excluded
earlier and found no signiﬁcant diﬀerences regarding the
tested variables. All subjects understood the nature of the
researchprojectandprovidedwritteninformedconsent.The
study protocol was reviewed and approved by the Ethics
Committee of Kyushu Dental College (No. 05022250).
Before beginning the examinations, each subject was
askedtorespondtoasurveyconductedbyadentalnursethat
consisted of questions related to general medical condition,
medication usage, lifestyle, oral health behavior, and oral
hygiene habits, and each was also questioned verbally to
obtain information regarding smoking status (never, past, or
current). The subjects were classiﬁed as either never-smokers
or smokers (i.e., past, current) on the basis of their answers.
Furthermore, a method that used face-scale scores was used
to evaluate self-rated health status [10]. From those scores,
the subjects were divided into three groups based on overall
health (moderate, good, and very good).
2.2. Biomarker Analyses. Saliva samples were collected from
all subjects between 11:00 AM and 1:00 PM to minimize any
circadian rhythm eﬀects, after they had refrained from oral
intake for at least 2 hours prior to collection. Subjects with
removable partial dentures kept them in their mouth during
saliva collection. Collection of stimulated whole saliva was
performed using sterile tubes. The subjects were ﬁrst asked
to swallow all saliva in the mouth, then chew paraﬃnf o r3
minutes at aconstantpace of60 times perminute, whichwas
monitored with an electric metronome. Collected samples
were placed on ice immediately and the salivary ﬂow rate
(mL/min) was estimated by measuring the volume of saliva
collected in the tube. Thereafter, the saliva samples were
frozen at −30
◦C until further analysis. The concentration
of cortisol in saliva (ng/mL) was measured using a salivary
cortisol enzyme immunoassay kit (Salimetrics, State College,
PA), with a lower sensitivity limit of 0.07ng/mL, while that
of DHEA (pg/mL) was determined using a salivary DHEA
enzyme immunoassay kit (Salimetrics, State College, PA),
with a lower sensitivity limit of 10pg/mL.
2.3. Clinical Examinations. Periodontal status was evaluated
using probing depth (PD), bleeding on probing (BOP), and
clinical attachment loss (CAL). Periodontal examinations
were conducted at two sites (mesio-buccal, mid-buccal) of
all teeth examined, using a standard periodontal probe (Hu-
Friedy, Chicago, IL.) that was inserted into the periodontal
pocket parallel to the long axis of all teeth fully erupted
in the mouth, according to a modiﬁed method described
in the Third National Health and Nutrition Examination
Survey (NHANES III) [11], with some modiﬁcations. All
periodontal examinations were performed by two dentists.
To conﬁrm interexaminer reliability, duplicate examinations
were conducted with 10 outpatients who were visiting
Kyushu Dental College Hospital. The intraclass correlation
coeﬃcients between examiners for assessment of PD and
CAL were 0.72 (95% conﬁdence interval (CI) 0.56–0.82)
and 0.74 (95% CI 0.60–0.84), respectively, while those for
intraexaminer were 0.78 (95% CI 0.66–0.87) and 0.84 (95%
CI 0.74–0.90), respectively. Severe periodontitis was deﬁned
as maximum PD ≥ 5mm or maximum CAL ≥ 6mm using
the mean value of each cutoﬀ point. Further, in order to
evaluate extensive periodontitis, we divided the subjects into
three categories (none, low, and high) according to the
number of teeth with maximum PD ≥ 5mm or CAL≥
6mm, as described previously [9]. Thus, for those with PD,
the none group included subjects with no teeth with PD ≥
5mm, while the low group included those with less than 3
teeth with PD ≥ 5mm, and the high group those with 3 or
m o r et e e t hw i t hP D≥ 5mm involved. As for CAL, the none
group included subjects with no teeth with CAL ≥ 6mm,
whilethelowgroupincludedthosewithlessthan3teethwith
CAL ≥ 6mm, and the high group those with 3 or more teeth
with CAL ≥ 6mminvolved.
2.4. Statistical Analysis. In order to assess diﬀerences among
the groups, a chi-square test was used for categorized
variablesandaKruskal-WallistestorANOVAforcontinuous
variables. If a normal distribution was not present according
to the results of a Kolomogorov-Smirnov test, the former test
was used.
Receiver operating characteristics (ROCs) analyses were
performed to determine the optimum cutoﬀ values for the
concentrations of cortisol and DHEA, which were used to
screen for severe periodontal status. Subjects with severe
periodontal status were dichotomized into periodontitis-
negative (i.e., none = 0) and periodontitis-positive (i.e.,
low and high = 1), based on the PD and CAL levels. This
dichotomy was then used to calculate the sensitivity and
speciﬁcity for the cutoﬀ values of cortisol and DHEA. ROCInternational Journal of Dentistry 3
Table 1: Subject characteristics by smoking status based on PD levels.
Number of teeth with PD ≥ 5mm ∗
Never-smokers Smokers
Characteristics None Low High P value None Low High P value
Number 59 41 13 28 22 8
Age in years
Mean 67.4 69.4 69.5 .043 66.8 69.7 69.6 .065
(SD) (4.4) (3.8) (4.2) (4.5) (5.2) (3.7)
Number of teeth
Mean 23.2 22.0 21.5 .565 25.0 20.2 22.5 .030
(SD) (7.0) (6.1) (5.0) (5.1) (7.3) (6.5)
Site with BOP
Mean 2.9 4.5 8.0 .003 2.6 4.7 5.5 .149
(SD) (4.0) (4.6) (8.0) (3.8) (4.4) (6.9)
Sex
Male 13 (22) 11 (27) 5 (38) .460 27 (96) 21 (96) 8 (100) .833
Social class
Non-workers 54 (92) 33 (80) 12 (92) .494 27 (97) 20 (91) 8 (100) .203
Medication 32 (54) 22 (54) 6 (46) .866 13 (46) 14 (64) 6 (75) .256
Use of interdental brush
Yes 32 (54) 21 (51) 7 (54) .955 12 (43) 10 (46) 5 (63) .612
Dental visit in past 12 months
Yes 31 (48) 24 (59) 8 (62) .759 17 (61) 12 (54) 3 (38) .506
Frequency of tooth brushing (per day)
≤1 time 3 (5) 7 (17) 2 (15) .389 7 (25) 8 (36) 7 (88) .029
2 times 36 (61) 23 (56) 7 (54) 14 (50) 9 (41) 0 (0)
≥3 times 20 (34) 11 (27) 4 (31) 7 (25) 5 (23) 1 (13)
Self-rated health status
Very good 16 (27) 17 (41) 10 (77) .016 12 (43) 10 (46) 2 (25) .001
Good 38 (64) 20 (49) 2 (15) 16 (57) 12 (55) 3 (38)
Moderate 5 (8) 4 (10) 1 (8) 0 (0) 0 (0) 3 (38)
∗Deﬁned by the number of teeth (no teeth, less than three teeth, three or more teeth) with PD ≥ 5mm. Categorical variables indicate the number of subjects
(%). Diﬀerences between groups were tested using a chi-square test for categorical variables and ANOVA for continuous variables. PD: probing depth (mm).
BOP: bleeding on probing.
curves were plotted for cortisol and DHEA with PD and CAL
and the area under the ROC curve (AUC) was calculated for
each. The optimum sensitivity and corresponding speciﬁcity
were determined from the point on the plot that was closest
to the top left-hand corner of the axes. All statistical analyses
were performed using SPSS 14.0 for Windows. The level
of statistical signiﬁcance was set at 0.05 for all of the
analyses.
3. Results
Tables 1 and 2 show subject characteristics of the 3 groups
divided according to PD and CAL stratiﬁed by smoking
status, which were used to analyze the relationships of
cortisol and DHEA levels in saliva with periodontal health
status. For PD in never-smokers, there were signiﬁcant
diﬀerences among the groups regarding age, BOP, and self-
rated health status (based on face-scale score), while there
were also signiﬁcant diﬀerences for the number of teeth,
frequency of tooth brushing, and self-rated health status
in the smokers group (Table 1). As for CAL there were
signiﬁcant diﬀerences regarding sex and BOP in the never-
smokers, while there were signiﬁcant diﬀerences between
age and self-rated health status in the smokers (Table 2). As
shown in Tables 1 and 2, most of the smokers were male
(approximately 96%).
Among never-smokers, the median and 25th and 75th
percentile values for cortisol were 1.87, 1.42, and 2.89
(ng/mL), respectively, while those for DHEA were 59.79,
32.69, and 89.52 (pg/mL), respectively. In contrast, among
smokers, the median and 25th and 75th percentile values
for cortisol were 2.18, 1.41, and 3.01 (ng/mL), respectively,
while those for DHEA were 46.07, 30.07, and 89.77 (pg/mL),
respectively. However, there were no signiﬁcant diﬀerences
regarding those hormone levels between smokers and never-
smokers. We compared the levels of cortisol and DHEA4 International Journal of Dentistry
Table 2: Subject characteristics by smoking status based on CAL levels.
Number of teeth with PD ≥ 6mm ∗
Never-smokers Smokers
Characteristics None Low High P value None Low High P value
Number 67 32 14 26 18 14
Age in years
Mean 68.2 68.1 70.1 .287 66.5 69.7 69.8 .034
(SD) (4.5) (3.9) (3.8) (4.1) (4.7) (5.4)
Number of teeth
Mean 23.4 22.2 19.4 .101 23.9 23.3 20.3 .222
(SD) (6.5) (6.7) (5.2) (6.6) (5.1) (7.5)
Site with BOP
Mean 3.0 5.9 5.4 .014 3.8 3.6 4.0 .972
(SD) (4.2) (5.5) (6.3) (5.1) (3.4) (5.3)
Sex
Male 12 (18) 9 (28) 8 (57) .009 25 (96) 17 (94) 14 (100) .686
Social class
Non-workers 61 (91) 26 (81) 12 (86) .614 25 (96) 16 (89) 14 (100) .601
Medication 38 (56) 15 (49) 7 (50) .636 13 (50) 11 (61) 6 (64) .623
Use of interdental brush
Yes 34 (51) 20 (63) 6 (43) .392 10 (39) 8 (44) 9 (64) .289
Dental visit in past 12 months
Yes 33 (49) 21 (66) 9 (64) .244 16 (62) 10 (56) 6 (43) .526
Frequency of tooth brushing (per day)
≤1 time 6 (9) 3 (9) 3 (21) .366 6 (23) 10 (56) 6 (43) .289
2 times 40 (60) 21 (66) 5 (36) 13 (50) 5 (28) 5 (36)
≥3 times 21 (31) 8 (25) 6 (43) 7 (27) 3 (17) 3 (21)
Self-rated health status
Very good 22 (33) 14 (44) 7 (50) .704 12 (46) 8 (44) 4 (29) .037
Good 39 (58) 15 (47) 6 (43) 14 (54) 10 (56) 7 (50)
Moderate 6 (9) 3 (9) 1 (7) 0 (0) 0 (0) 3 (21)
∗Deﬁned by the number of teeth (no teeth, less than three teeth, three or more teeth) with PD ≥ 6mm. Categorical variables indicate the number of subjects
(%). Diﬀerences between groups were tested using a chi-square test for categorical variables and ANOVA for continuous variables. CAL: clinical attachment
level (mm). BOP: bleeding on probing.
betweenthewithandwithoutextensiveperiodontitisgroups,
which were deﬁned by the number of teeth with PD ≥
5mm or CAL≥ 6mm. Table 3 shows the results of that
comparison in the never-smokers, while Table 4 shows the
results for smokers. As for the levels of both in the never-
smokers, signiﬁcant diﬀerences were found among the three
categories deﬁned by PD and CAL, and higher hormone
levels were found in subjects with severe PD or CAL.
However, in smokers, no signiﬁcant diﬀerences were found
among the 3 categories deﬁned by PD or CAL. In contrast, in
comparisons of salivary ﬂow rate, there were no signiﬁcant
diﬀerences among the three categories for both PD and CAL,
irrespective of smoking status (Tables 3 and 4).
Next we evaluated the usefulness of measuring cortisol
and DHEA levels to screen for periodontitis in never-
smokers with the above-mentioned associations. For that
purpose, we performed ROC analysis to discriminate
between false-positive and true-positive diagnoses of severe
periodontitis (i.e., low and high) at various cutoﬀ levels. The
area under the curve (AUC) for PD was 0.68 (95% CI 0.58–
0.78, P = .001) and 0.69 (95% CI 0.59–0.79, P<. 001)
for cortisol and DHEA, respectively (Figure 1). For CAL,
the AUC was 0.71 (95% CI 0.62–0.81, P<. 001) and 0.68
(95% CI 0.58–0.78, P = .002) for cortisol and DHEA,
respectively (Figure 2). As shown in Table 5, the optimal
sensitivity and speciﬁcity of cortisol for PD were 0.63 and
0.71, respectively, while they were 0.67 and 0.66, respectively,
forDHEA,withcutoﬀvaluesof2.06(ng/mL)forcortisoland
60.24 (pg/mL) for DHEA, which indicated a corresponding
level in the 55th and 51st percentile, respectively. As shown
in Table 6, the optimal sensitivity and speciﬁcity of cortisol
for CAL were 0.70 and 0.73, respectively, while they were
0.63 and 0.64, respectively, for DHEA, with cutoﬀ values
of 2.12 (ng/mL) for cortisol and 61.78 (pg/mL) for DHEA,
which indicated a corresponding level in the 56th and 54th
percentile, respectively.International Journal of Dentistry 5
Table 3: Median values for salivary cortisol and dehydroepiandrosterone in presence or absence of extensive periodontitis in subjects who
never smoked, divided by PD and CAL.
Categories divided by PD∗
None Low High P value†
Number 59 41 13
Cortisol (ng/mL)
Median 1.68 2.32 3.10 .002
(25th, 75th percentile) (1.29, 2.40) (1.58, 3.31) (2.08, 3.62)
DHEA (pg/mL)
Median 47.22 68.99 119.01 <.001
(25th, 75th percentile) (28.50, 70.29) (37.49, 97.93) (79.67, 137.93)
Salivary ﬂow rate (mL/min)
Median 0.90 0.97 0.90 .578
(25th, 75th percentile) (0.67, 1.13) (0.67, 1.33) (0.60, 1.52)
Categories divided by CAL∗
None Low High P value†
Number 67 32 14
Cortisol (ng/mL)
Median 1.64 2.49 2.98 <.001
(25th, 75th percentile) (1.29, 2.39) (1.75, 3.10) (1.84, 3.67)
DHEA (pg/mL)
Median 54.28 66.60 104.44 .003
(25th, 75th percentile) (28.50, 76.69) (41.57, 111.30) (68.62, 122.41)
Salivary ﬂow rate (mL/min)
Median 0.93 1.08 0.75 .092
(25th, 75th percentile) (0.67, 1.17) (0.73, 1.38) (0.31, 1.06)
∗Deﬁned by the number of teeth (no teeth, less than 3 teeth, 3 or more teeth) with PD ≥ 5mmorCAL≥ 6mm. DHEA: dehydroepiandrosterone. PD:
probing depth (mm). CAL: clinical attachment loss (mm). †Kruskal-Wallis test.
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Figure 1: ROC curves used for the cutoﬀ values of cortisol (ng/mL)
and DHEA (pg/mL) in saliva to screen PD levels in never-smokers.
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Figure 2: ROC curves used for the cutoﬀ values of cortisol (ng/mL)
andDHEA(pg/mL)insalivatoscreenCALlevelsinnever-smokers.6 International Journal of Dentistry
Table 4: Median values for salivary cortisol and dehydroepiandrosterone in presence or absence of extensive periodontitis in subjects who
smoked, divided by PD and CAL.
Categories divided by PD∗
None Low High P value†
Number 28 22 8
Cortisol (ng/mL)
Median 2.01 2.13 2.44 .573
(25th, 75th percentile) (1.41, 3.13) (1.36, 2.73) (1.98, 3.13)
DHEA (pg/mL)
Median 36.72 48.70 94.75 .173
(25th, 75th percentile) (28.44, 82.12) (30.07, 89.77) (46.67, 121.26)
Salivary ﬂow rate (mL/min)
Median 0.87 0.80 0.92 .494
(25th, 75th percentile) (0.51, 1.26) (0.29, 1.19) (0.69, 1.25)
Categories divided by CAL∗
None Low High P value†
Number 26 18 14
Cortisol (ng/mL)
Median 2.01 2.09 2.59 .243
(25th, 75th percentile) (1.29, 2.58) (1.42, 3.09) (1.68, 3.43)
DHEA (pg/mL)
Median 45.12 44.30 55.98 .633
(25th, 75th percentile) (32.99, 85.14) (19.49, 95.35) (30.54, 114.47)
Salivary ﬂow rate (mL/min)
Median 0.90 0.88 0.59 .079
(25th, 75th percentile) (0.66, 1.21) (0.57, 1.56) (0.29, 1.05)
∗Deﬁned by the number of teeth (no teeth, less than 3 teeth, 3 or more teeth) with PD ≥ 5mmorCAL≥ 6mm. DHEA: dehydroepiandrosterone. PD:
probing depth (mm). CAL: clinical attachment loss (mm). †Kruskal-Wallis test.
Table 5: Cutoﬀ values for cortisol and DHEA in saliva for optimal
sensitivity and speciﬁcity obtained from ROC curve for PD levels in
never-smokers.
Cutoﬀ value Optimal
sensitivity
Optimal
speciﬁcity
Cortisol (ng/mL) 2.06 0.63 0.71
DHEA (pg/mL) 60.24 0.67 0.66
Table 6: Cutoﬀ values for cortisol and DHEA in saliva for optimal
sensitivity and speciﬁcity obtained from ROC curve for CAL levels
in never-smokers.
Cutoﬀ value Optimal
sensitivity
Optimal
speciﬁcity
Cortisol (ng/mL) 2.12 0.70 0.73
DHEA (pg/mL) 61.78 0.63 0.64
4. Discussion
In the present cross-sectional study, we investigated cortisol
and DHEA levels and periodontal status in elderly subjects
and found that levels of the salivary stress-related hormones
cortisol and DHEA were useful for screening for periodonti-
tis in subjects who had never smoked.
The association between periodontitis and stress-related
hormones has been largely overlooked, with only two known
human studies of the associations between cortisol in saliva
and periodontitis reported. One of those was our own survey
[9], while the other was a report by Hilgert et al. [12]. In the
latter, the authors found a positive association between sali-
vary cortisol and periodontitis, while hypercortisolemia was
independently associated with the severity of periodontitis,
as deﬁned by CAL (mean CAL ≥ 4mmversus< 4mm), and
the extent of periodontitis, as deﬁned by PD (≥26% versus
<26% of sites with PD ≥ 4mm) or CAL (≥30% of sites with
CAL ≥ 5mmversus< 30%). However, smoking status was
removed from the ﬁnal model of logistic regression analysis
in that report, while we did not treat smoking as a factor
based on stratiﬁcation of smoking status. In a recent study,
treatment of smoking as a confounding factor resulted in a
greatly underestimated magnitude of association [13].
Smoking is known to be associated with elevated cor-
tisol and DHEA levels. In a recent report that compared
cortisol proﬁles of smokers and nonsmokers over the day,
cortisol levels were elevated in everyday life among smokers
compared with nonsmokers, and the diﬀerences in values
were quite substantial, averaging 35% or more on both
working and weekend days [6]. In the present study,
cortisol levels were higher in smokers than never-smokers,
though the diﬀerences were not signiﬁcant (2.18 versusInternational Journal of Dentistry 7
1.87ng/mL). Furthermore, salivary levels of cortisol and
DHEA were signiﬁcantly elevated according to the severity
of periodontitis, in our never-smoked subjects, whereas
no signiﬁcant association was observed in smokers. One
possible explanation for these ﬁndings might be that the
capability of those hormones to diﬀerentiate periodontally
aﬀected patients from periodontally healthy individuals is
weaker than that of smoking. Conversely, since smoking
itself is a stronger risk factor for periodontitis than other
known risk factors, evaluation of smoking behavior may be a
superior screening method for smokers.
Measurement of biomarkers in saliva has many advan-
tages, as the procedure is stress-free and noninvasive, and
allows for frequent and rapid sampling, whereas diurnal
rhythm, artiﬁcial changes due to food or drinking sub-
stances, and blood-contamination are some of the disad-
vantages. Thus, as described above in the Methods section,
the sampling method must be carefully performed. In order
to minimize any circadian rhythm eﬀects, we selected the
period between 11:00 AM and 1:00 PM for obtaining saliva
samples, which has been reported to be stable in regard to
daytime hormones levels in nonsmokers [6].
A periodontal probe is generally used for periodontitis
screening during community-based oral health check-ups,
though several problems, including cost, burden on the
subject, prevention of infection, and manpower needs,
have been pointed out. Our analysis using ROC curves
showedacceptablesensitivityandspeciﬁcityforperiodontitis
screening with both of the salivary hormones tested in the
present study. On the other hand, progress is being made in
the development of various screening tests for periodontitis
using enzymes [14], cytokines [15], and antimicrobial
proteins [16] in saliva. We think that it would be better to
combine several tests that reﬂect the multiple risk factors
associated with periodontitis and not depend on results of
a single test. On the other hand, it is important to consider
the cost-eﬀectiveness when promoting such screening tests
for clinical use. A commercial test kit for cortisol costs
approximately US$ 250 and can be used 50 subjects, that
is, US$ 5.00 per test. However, additional costs must be
added when considering the required manpower for the
assay and other laboratory charges. In the near future, it is
anticipated that screening tests used for a large population
will be noninvasive and less burdensome for the subjects,
with no requirements of speciﬁc devices or instruments, or
forindividualexaminationsbyanexpertaswellasreasonable
cost-eﬀectiveness performance.
A limitation of the present study is that our subjects
were generally in good health and noninstitutionalized. In
addition, the percentage of subjects with severely extensive
periodontitis among all subjects analyzed was low. Thus,
these ﬁndings may indicate that the association exists pri-
marily in systemically and orally healthy elderly individuals.
Furthermore, it is possible that the periodontal examination
method that utilized two sites per tooth in this study, which
was based on NHANS III, may underestimate the severity
and extent of periodontitis. Additional investigations are
necessary to validate and extend the ﬁndings using other
ages or outpatients. Further, the usefulness of cortisol and
DHEA as predictors for periodontitis cannot be determined
from our ﬁndings, and a longitudinal study is necessary
to determine the relationships of those hormones to the
progression of periodontitis.
In summary, we found a signiﬁcant association between
the salivary steroid hormones cortisol and DHEA and
periodontitis severity in community-dwelling elderly sub-
jects who had never smoked. These results indicate that
these stress-related hormones are useful indicators of the
risk for periodontitis, as they showed moderate levels of
sensitivity and speciﬁcity for periodontitis. Within the study
limitations regarding smoking status, the present method
of determining cortisol and DHEA levels may include a
possibility as screening test for periodontal disease in the
near future. Additional approaches to reveal a new type of
screening test system for periodontitis as an alternative to the
conventional probing method are required.
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